118 related articles for article (PubMed ID: 16133934)
1. Giant cells: contradiction to two-hit model of tuber formation?
Jozwiak J; Jozwiak S
Cell Mol Neurobiol; 2005 Aug; 25(5):795-805. PubMed ID: 16133934
[TBL] [Abstract][Full Text] [Related]
2. Giant cells: contradiction to two-hit model of tuber formation?
Jozwiak J; Jozwiak S
Cell Mol Neurobiol; 2007 Mar; 27(2):251-61. PubMed ID: 16897363
[TBL] [Abstract][Full Text] [Related]
3. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.
Mizuguchi M
Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and microscopic studies on giant cells in tuberous sclerosis.
Jozwiak J; Jozwiak S; Skopinski P
Histol Histopathol; 2005 Oct; 20(4):1321-6. PubMed ID: 16136513
[TBL] [Abstract][Full Text] [Related]
5. Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis.
Jóźwiak S; Kwiatkowski D; Kotulska K; Larysz-Brysz M; Lewin-Kowalik J; Grajkowska W; Roszkowski M
J Child Neurol; 2004 Feb; 19(2):102-6. PubMed ID: 15072102
[TBL] [Abstract][Full Text] [Related]
6. Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin.
Wei J; Li P; Chiriboga L; Mizuguchi M; Yee H; Miller DC; Greco MA
Pediatr Dev Pathol; 2002; 5(5):448-64. PubMed ID: 12202993
[TBL] [Abstract][Full Text] [Related]
7. Minute amounts of hamartin wildtype rescue the emergence of tuber-like lesions in conditional Tsc1 ablated mice.
Robens BK; Grote A; Pitsch J; Schoch S; Cardoso C; Becker AJ
Neurobiol Dis; 2016 Nov; 95():134-44. PubMed ID: 27425891
[TBL] [Abstract][Full Text] [Related]
8. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex.
Hino O; Kobayashi T
Cancer Sci; 2017 Jan; 108(1):5-11. PubMed ID: 27862655
[TBL] [Abstract][Full Text] [Related]
9. Aspects of tuberous sclerosis complex (TSC) protein function in the brain.
Ramesh V
Biochem Soc Trans; 2003 Jun; 31(Pt 3):579-83. PubMed ID: 12773159
[TBL] [Abstract][Full Text] [Related]
10. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
Grajkowska W; Kotulska K; Matyja E; Larysz-Brysz M; Mandera M; Roszkowski M; Domańska-Pakieła D; Lewik-Kowalik J; Jóźwiak S
Folia Neuropathol; 2008; 46(1):43-8. PubMed ID: 18368626
[TBL] [Abstract][Full Text] [Related]
11. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
Plank TL; Logginidou H; Klein-Szanto A; Henske EP
Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
[TBL] [Abstract][Full Text] [Related]
12. Transgenic expression of dominant negative tuberin through a strong constitutive promoter results in a tissue-specific tuberous sclerosis phenotype in the skin and brain.
Govindarajan B; Brat DJ; Csete M; Martin WD; Murad E; Litani K; Cohen C; Cerimele F; Nunnelley M; Lefkove B; Yamamoto T; Lee C; Arbiser JL
J Biol Chem; 2005 Feb; 280(7):5870-4. PubMed ID: 15576369
[TBL] [Abstract][Full Text] [Related]
13. Absence of allelic loss in cytomegalic neurons of cortical tuber in the Eker rat model of tuberous sclerosis.
Mizuguchi M; Mori M; Nozaki Y; Momoi MY; Itoh M; Takashima S; Hino O
Acta Neuropathol; 2004 Jan; 107(1):47-52. PubMed ID: 14566415
[TBL] [Abstract][Full Text] [Related]
14. Tuberous sclerosis complex.
Islam MP; Roach ES
Handb Clin Neurol; 2015; 132():97-109. PubMed ID: 26564073
[TBL] [Abstract][Full Text] [Related]
15. Brain lesions in tuberous sclerosis complex. Review.
Grajkowska W; Kotulska K; Jurkiewicz E; Matyja E
Folia Neuropathol; 2010; 48(3):139-49. PubMed ID: 20924998
[TBL] [Abstract][Full Text] [Related]
16. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex.
Al-Saleem T; Wessner LL; Scheithauer BW; Patterson K; Roach ES; Dreyer SJ; Fujikawa K; Bjornsson J; Bernstein J; Henske EP
Cancer; 1998 Nov; 83(10):2208-16. PubMed ID: 9827727
[TBL] [Abstract][Full Text] [Related]
17. [Tests for loss of heterozygosity in tuberous sclerosis].
Jóźwiak S; Dabora S; Kasprzyk-Obara J; Domańska-Pakieła D; Grajkowska W
Przegl Lek; 2001; 58 Suppl 1():12-5. PubMed ID: 11355103
[TBL] [Abstract][Full Text] [Related]
18. Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas.
Carbonara C; Longa L; Grosso E; Mazzucco G; Borrone C; Garrè ML; Brisigotti M; Filippi G; Scabar A; Giannotti A; Falzoni P; Monga G; Garini G; Gabrielli M; Riegler P; Danesino C; Ruggieri M; Magro G; Migone N
Genes Chromosomes Cancer; 1996 Jan; 15(1):18-25. PubMed ID: 8824721
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity in tuberous sclerosis hamartomas.
Sepp T; Yates JR; Green AJ
J Med Genet; 1996 Nov; 33(11):962-4. PubMed ID: 8950679
[TBL] [Abstract][Full Text] [Related]
20. The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27.
Rosner M; Freilinger A; Hengstschläger M
Mutat Res; 2006 Sep; 613(1):10-6. PubMed ID: 16713332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
